Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 22;13:3389–3399. doi: 10.2147/OTT.S249662

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Jin et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

miR-934 directly targeted and inhibited PROX1 expression. (A) The correlation analysis between miR-934 and PROX1 performed using expression data from the TCGA database. (B) Western blot analysis used to detect the expression of PROX1 in different miR-934 expression cell lines. GAPDH was used as an internal control. (C) The relative gray level of Western blot was quantified and analyzed. (D) PROX1 mRNA expression level in cells transfected with miR-934 mimics or inhibitor was measured by qRT-PCR. (E) Potential binding targets of miR-934 to PROX1 predicted by the targetScan database. (F) Dual-luciferase reporter assay used to verify the direct binding of miR-934 to PROX1. *P < 0.05, **P < 0.01, ***P < 0.001, ns: not significant.